Patrick D. Walsh
Pat has over thirty-five years of experience in the healthcare industry with extensive experience directing pharmaceutical manufacturing operations on a global scale in parenteral, API, specialty pharmaceutical, formulation, manufacturing and analytical contract development organizations. Most recently, he served as the CEO of Avista Pharma Solutions and drove the rapid growth of the business, resulting in a pre-emptive sale of the company to Cambrex Corp in January 2019 for $252 million. Before Avista, he was CEO of AAIPharma Services and led the successful growth strategy, culminating in the sale of the company for 4.6 times return on invested capital. Pat serves as an independent director of Avid Bioservices, MedPharm, and ANI Pharma. Prior board of director roles includes serving as Chairman of Brammer Bio and numerous other pharma and biotechnology companies.